Medication taking in coronary artery disease: A systematic review and qualitative synthesis

Annals of Family Medicine

Volumn 12, Issue 3, 2014, Pages 224-232

  Rashid, Mohammed A ^a   Edwards, Duncan ^a   Walter, Fiona M ^a   Mant, Jonathan ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Adherence; Compliance; Coronary artery disease; Drug therapy; Heart disease; Medication; Patient behavior; Persistence; Qualitative research; Secondary prevention

Indexed keywords

ATTITUDE TO HEALTH; CORONARY ARTERY DISEASE; DOCTOR PATIENT RELATION; HUMAN; MEDICATION COMPLIANCE; PSYCHOLOGY; SECONDARY PREVENTION; STATISTICS AND NUMERICAL DATA;

ATTITUDE TO HEALTH; CORONARY ARTERY DISEASE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MEDICATION ADHERENCE; PHYSICIAN-PATIENT RELATIONS; SECONDARY PREVENTION;

EID: 84900436894     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.1620     Document Type: Article

References (49)

1. Scarborough P, Bhatnagar P, Wickramasinghe K, Smolina K, Mitchell C, Rayner M. Coronary Heart Disease Statistics. London, England: British Heart Foundation; 2010.
2. Mackay J, Mensah G. The Atlas of Heart Disease and Stroke. Geneva, Switzerland: World Health Organization; 2004.
3. Parodi G, Memisha G, Valenti R, et al. Five year outcome after primary coronary intervention for acute ST elevation myocardial infarction: results from a single centre experience. Heart. 2005; 91(12):1541-1544.
4. Tendera M. How much does Europe invest in the treatment of cardiovascular diseases? Eur Heart J. 2006;27(13):1521-1522.
5. Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006;27(13):1610-1619.
6. DeWilde S, Carey IM, Richards N, Whincup PH, Cook DG. Trends in secondary prevention of ischaemic heart disease in the UK 1994-2005: use of individual and combination treatment. Heart. 2008; 94(1):83-88.
7. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil. 2009;16(2):121-137.
8. Vrijens B, De Geest S, Hughes DA, et al; ABC Project Team. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691-705.
9. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113(24):2803-2809.
10. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166(17):1842-1847.
11. Ellison KE, Gandhi G. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease. Drugs. 2005;65(6):787-797.
12. Neubeck L, Freedman SB, Clark AM, Briffa T, Bauman A, Redfern J. Participating in cardiac rehabilitation: a systematic review and metasynthesis of qualitative data. Eur J Prev Cardiol. 2012;19(3):494-503.
13. Bethell H, Lewin R, Dalal H. Cardiac rehabilitation in the United Kingdom. Heart. 2009;95(4):271-275.
14. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007; 356(23):2388-2398.
15. Doherty WJ, Schrott HG, Metcalf L, Iasiello-Vailas L. Effect of spouse support and health beliefs on medication adherence. J Fam Pract. 1983;17(5):837-841.
16. Brecht ML, Dracup K, Moser DK, Riegel B. The relationship of marital quality and psychosocial adjustment to heart disease. J Cardiovasc Nurs. 1994;9(1):74-85.
17. Jones ML. Application of systematic review methods to qualitative research: practical issues. J Adv Nurs. 2004;48(3):271-278.
18. Campbell R, Pound P, Morgan M, et al. Evaluating meta-ethnography: systematic analysis and synthesis of qualitative research. Health Technol Assess. 2011;15(43):1-164.
19. Noblit G, Hare R. Meta-Ethnography: Synthesising Qualitative Studies. Newbury Park, CA: Sage Publications; 1988.
20. Evans D. Database searches for qualitative research. J Med Libr Assoc. 2002;90(3):290-293.
21. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA. 1992;268(2):240-248.
22. Smith LK, Pope C, Botha JL. Patients' help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet. 2005;366(9488):825-831.
23. Critical Appraisal Skills Programme (CASP). 10 questions to help you make sense of qualitative research. Qualitative checklist 14.10.10. http://www.casp-uk.net/wp-content/uploads/2011/11/ CASP_Qualitative_Appraisal_Checklist_14oct10.pdf. Accessed Sep 7, 2013.
24. Dixon-Woods M, Sutton AJ, Shaw RL, et al. Appraising qualitative research for inclusion in systematic reviews: a quantitative and qualitative comparison of three methods. J Health Serv Res Policy. 2007;12(1):42-47.
25. Britten N, Campbell R, Pope C, Donovan J, Morgan M, Pill R. Using meta ethnography to synthesise qualitative research: a worked example. J Health Serv Res Policy. 2002;7(4):209-215.
26. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
27. Roebuck A, Furze G, Thompson DR. Health-related quality of life after myocardial infarction: an interview study. J Adv Nurs. 2001; 34(6):787-794.
28. Wiles R, Kinmonth A. Patients' understandings of heart attack: implications for prevention of recurrence. Patient Educ Couns. 2001;44(2):161-169.
29. Bergman E, Berterö C. You can do it if you set your mind to it: a qualitative study of patients with coronary artery disease. J Adv Nurs. 2001;36(6):733-741.
30. Kärner A, Göransson A, Bergdahl B. Conceptions on treatment and lifestyle in patients with coronary heart disease-a phenomenographic analysis. Patient Educ Couns. 2002;47(2):137-143.
31. Webster RA, Thompson DR, Mayou RA. The experiences and needs of Gujarati Hindu patients and partners in the first month after a myocardial infarction. Eur J Cardiovasc Nurs. 2002;1(1):69-76.
32. Tolmie EP, Lindsay GM, Kerr SM, Brown MR, Ford I, Gaw A. Patients' perspectives on statin therapy for treatment of hypercholesterolaemia: a qualitative study. Eur J Cardiovasc Nurs. 2003;2(2):141-149.
33. Kärner A, Dahlgren MA, Bergdahl B. Coronary heart disease: causes and drug treatment-spouses' conceptions. J Clin Nurs. 2004;13(2): 167-176.
34. Attebring MF, Herlitz J, Ekman I. Intrusion and confusion-the impact of medication and health professionals after acute myocardial infarction. Eur J Cardiovasc Nurs. 2005;4(2):153-159.
35. Lehane E, McCarthy G, Collender V, Deasy A. Medication-taking for coronary artery disease-patients' perspectives. Eur J Cardiovasc Nurs. 2008;7(2):133-139.
36. Wang W, Thompson DR, Chair SY, Twinn SF. Chinese couples' experiences during convalescence from a first heart attack: a focus group study. J Adv Nurs. 2008;61(3):307-315.
37. Decker C, Garavalia L, Garavalia B, Spertus JA. Clopidogrel-taking behavior by drug-eluting stent patients: discontinuers versus continuers. Patient Prefer Adherence. 2008;2(2):167-175.
38. Garavalia L, Garavalia B, Spertus JA, Decker C. Exploring patients' reasons for discontinuance of heart medications. J Cardiovasc Nurs. 2009;24(5):371-379.
39. Garavalia L, Ho PM, Garavalia B, et al. Clinician-patient discord: exploring differences in perspectives for discontinuing clopidogrel. Eur J Cardiovasc Nurs. 2011;10(1):50-55.
40. West D, Lefler L, Franks A. Examining medication adherence in older women with coronary heart disease. J Women Aging. 2010;22(3): 157-170.
41. White S, Bissell P, Anderson C. Patients' perspectives on cardiac rehabilitation, lifestyle change and taking medicines: implications for service development. J Health Serv Res Policy. 2010;15(2 Suppl 2):47-53.
42. Speechly C, Bridges-Webb C, McKenzie S, Zurynski Y, Lucas A. Patient and general practitioner attitudes to healthy lifestyle behaviours and medication following coronary heart disease: an exploratory study. Aust J Prim Health. 2010;16(2):154-158.
43. Rushworth GF, Cunningham S, Mort A, Rudd I, Leslie SJ. Patientspecific factors relating to medication adherence in a postpercutaneous coronary intervention cohort. Int J Pharm Pract. 2012;20(4):226-237.
44. Williams G. The genesis of chronic illness: narrative re-construction. Sociol Health Illn. 1984;6(2):175-200.
45. Lam TP. Strengths and weaknesses of traditional Chinese medicine and Western medicine in the eyes of some Hong Kong Chinese. J Epidemiol Community Health. 2001;55(10):762-765.
46. Wood DA. Is cardiac rehabilitation fit for purpose in the NHS: maybe not. Heart. 2012;98(8):607-608.
47. Pound P, Britten N, Morgan M, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1): 133-155.
48. Byrne M, Walsh J, Murphy AW. Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour. J Psychosom Res. 2005;58(5):403-415.
49. Kronish IM, Rieckmann N, Halm EA, et al. Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med. 2006;21(11):1178-1183.